Nu-Med Plus (NUMD) Enterprise Value (2011 - 2025)
Nu-Med Plus (NUMD) reported Enterprise Value of -$661.0 for Q4 2025, up 72.14% on a YoY basis from -$383.98 in Q4 2024, and up 66.07% sequentially from -$1948.0 in Q3 2025.
Nu-Med Plus (NUMD) Enterprise Value (2011 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 15 years of Enterprise Value data on file, last reported at -$661.0 in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 72.14% year-over-year to -$661.0; the trailing twelve-month figure through Dec 2025 stood at -$661.0 (up 72.14% YoY), and the FY2025 full-year result was -$661.0, up 72.14% from the prior year.
- Enterprise Value grew to -$661.0 in Q4 2025, from -$1948.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$628.0 in Q3 2022 to a low of -$139265.0 in Q1 2021.
- A 5-year average of -$23974.1 and a median of -$6356.0 in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 98.18% in 2022 and tumbled 1990.22% in 2023, its largest moves.
- Tracing NUMD's Enterprise Value over 5 years: stood at -$11675.0 in 2021, then tumbled by 526.94% to -$73195.0 in 2022, then surged by 90.7% to -$6806.0 in 2023, then soared by 65.13% to -$2373.0 in 2024, then jumped by 72.14% to -$661.0 in 2025.
- Business Quant data shows NUMD's Enterprise Value at -$661.0 in Q4 2025, -$1948.0 in Q3 2025, and -$863.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -661.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -661.00 |
| Sep 30, 2025 | -1,948.00 |
| Jun 30, 2025 | -863.00 |
| Mar 31, 2025 | -2,373.00 |
| Dec 31, 2024 | -2,373.00 |
| Sep 30, 2024 | -4,041.00 |
| Jun 30, 2024 | -4,041.00 |
| Mar 31, 2024 | -6,356.00 |
| Dec 31, 2023 | -6,806.00 |
| Sep 30, 2023 | -11,088.00 |
| Jun 30, 2023 | -29,957.00 |
| Mar 31, 2023 | -53,029.00 |
| Dec 31, 2022 | -73,195.00 |
| Sep 30, 2022 | -628.00 |
| Mar 31, 2022 | -2,537.00 |
| Dec 31, 2021 | -11,675.00 |
| Sep 30, 2021 | -31,840.00 |
| Jun 30, 2021 | -72,831.00 |
| Mar 31, 2021 | -139,265.00 |
| Dec 31, 2020 | -188,506.00 |